Collaborative study of maternal urine β -core human chorionic gonadotrophin screening for Down syndrome
Authors:
- Howard S. CuckleHCHoward S. Cuckle
- Howard S. CuckleHCHoward S. Cuckle
- The Collaborative Study GroupTGThe Collaborative Study Group
- The Collaborative Study GroupTGThe Collaborative Study Group
- 15 October 1999
- journal article
- clinical trial
- Published by Wiley in Prenatal Diagnosis
- Vol. 19 (10) , 911-917
Abstract
Several studies have shown that second‐trimester maternal urine β‐core human chorionic gonadotrophin (hCG) levels are raised on average in Down syndrome pregnancies. However, in all but one, testing was retrospective after extended sample storage and so we carried out a large international multicentre prospective study. 16 centres provided 6730 samples from 14–19 week pregnancies: 39 with Down syndrome, 12 with Edwards' syndrome, 42 with other aneuploidies, 52 unaffected twins and 6585 singleton unaffected pregnancies. Samples were from those having routine maternal serum screening in 6 centres and invasive prenatal diagnosis for reasons unrelated to maternal serum screening in 10 centres. Normalized levels of β‐core hCG (nmom/mmol creatinine) were expressed as multiples of the gestation‐specific normal median (MoMs). The median β‐core hCG level in Down syndrome was 1.70 MoM (95 per cent confidence interval, 1.26–2.30); 14 (36 per cent) exceeded the normal 90th centile and 9 (23 per cent) the 95th centile. The median level in Edwards' syndrome was 0.23 MoM. On the basis of our results alone it is unlikely that urinary β‐core hCG will be a useful marker in Down syndrome screening practice. But the considerable variability in results between studies means that further research is needed before a reliable conclusion can be drawn. Copyright © 1999 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- Urinary screening tests for fetal Down syndrome: I. Fresh β-core fragmentPrenatal Diagnosis, 1999
- Comparison of urinary free beta (hCG) and beta-core (hCG) in prenatal screening for chromosomal abnormalitiesPrenatal Diagnosis, 1998
- Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndromePrenatal Diagnosis, 1997
- FIRST-TRIMESTER URINE FREE BETA hCG, BETA CORE, AND TOTAL OESTRIOL IN PREGNANCIES AFFECTED BY DOWN'S SYNDROME: IMPLICATIONS FOR FIRST-TRIMESTER SCREENING WITH NUCHAL TRANSLUCENCY AND SERUM FREE BETA hCGPrenatal Diagnosis, 1997
- SCREENING FOR DOWN SYNDROME PREGNANCY USING β-CORE FRAGMENT: PROSPECTIVE STUDYPrenatal Diagnosis, 1997
- Detection of β-core fragment in second trimester Down's syndrome pregnanciesEarly Human Development, 1996
- URINE FREE BETA hCG AND BETA CORE IN PREGNANCIES AFFECTED BY DOWN'S SYNDROMEPrenatal Diagnosis, 1996
- Second‐trimester levels of maternal urinary gonadotropin peptide in down syndrome pregnancyPrenatal Diagnosis, 1995
- Urinary multiple marker screening for down's syndromePrenatal Diagnosis, 1995
- Urinary β‐core human chorionic gonadotrophin: A new approach to Down's syndrome screeningPrenatal Diagnosis, 1994